BDNF as a biomarker for insomnia in hemodialysis patients: influence of hypnotic medication use.

Wang Y, Liu L, Li M, Chen Q, Yuan Q, Hua Q, Jin Z

Open source

DOI
10.1007/s11255-026-05375-y
Published
2026 Sep 7
Container
International urology and nephrology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11255-026-05375-y,
  title = {BDNF as a biomarker for insomnia in hemodialysis patients: influence of hypnotic medication use.},
  author = {Wang Y and Liu L and Li M and Chen Q and Yuan Q and Hua Q and Jin Z},
  year = {2026},
  journal = {International urology and nephrology},
  doi = {10.1007/s11255-026-05375-y},
  url = {https://doi.org/10.1007/s11255-026-05375-y}
}

RIS

TY  - JOUR
TI  - BDNF as a biomarker for insomnia in hemodialysis patients: influence of hypnotic medication use.
AU  - Wang Y
AU  - Liu L
AU  - Li M
AU  - Chen Q
AU  - Yuan Q
AU  - Hua Q
AU  - Jin Z
PY  - 2026
JO  - International urology and nephrology
DO  - 10.1007/s11255-026-05375-y
UR  - https://doi.org/10.1007/s11255-026-05375-y
ER  - 

APA

Y, W., L, L., M, L., Q, C., Q, Y., Q, H., & Z, J. (2026). BDNF as a biomarker for insomnia in hemodialysis patients: influence of hypnotic medication use.. International urology and nephrology. https://doi.org/10.1007/s11255-026-05375-y

Source records